-
1
-
-
77953228575
-
-
Amylin Pharmaceuticals Inc., San Diego, CA: Amylin Pharmaceuticals, Inc.,
-
2008, Amylin Pharmaceuticals Inc., San Diego, CA: Amylin Pharmaceuticals, Inc.,
-
(2008)
-
-
-
2
-
-
0036548068
-
A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes
-
Whitehouse F, Kruger DF, Fineman M. A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes. Diabetes Care 2002, 25:724-730.
-
(2002)
Diabetes Care
, vol.25
, pp. 724-730
-
-
Whitehouse, F.1
Kruger, D.F.2
Fineman, M.3
-
3
-
-
0036238808
-
Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes
-
Ratner RE, Want LL, Fineman MS. Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes. Diabetes Technol Ther 2002, 4:51-61.
-
(2002)
Diabetes Technol Ther
, vol.4
, pp. 51-61
-
-
Ratner, R.E.1
Want, L.L.2
Fineman, M.S.3
-
4
-
-
33747789575
-
Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes
-
Pullman J, Darsow T, Frias JP. Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes. Vasc Health Risk Manage 2006, 2:203-212.
-
(2006)
Vasc Health Risk Manage
, vol.2
, pp. 203-212
-
-
Pullman, J.1
Darsow, T.2
Frias, J.P.3
-
5
-
-
33747763918
-
A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes
-
Edelman S, Garg S, Frias J. A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes. Diabetes Care 2006, 29:2189-2195.
-
(2006)
Diabetes Care
, vol.29
, pp. 2189-2195
-
-
Edelman, S.1
Garg, S.2
Frias, J.3
-
6
-
-
34247535904
-
Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions and weight
-
Karl D, Philis-Tsimikas A, Darsow T. Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions and weight. Diabetes Technol Ther 2007, 9:191-199.
-
(2007)
Diabetes Technol Ther
, vol.9
, pp. 191-199
-
-
Karl, D.1
Philis-Tsimikas, A.2
Darsow, T.3
-
7
-
-
0041666594
-
Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use
-
Leese GP, Wang J, Broomhall J. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003, 26:1176-1180.
-
(2003)
Diabetes Care
, vol.26
, pp. 1176-1180
-
-
Leese, G.P.1
Wang, J.2
Broomhall, J.3
-
8
-
-
0023278491
-
Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT)
-
DCCT Research Group
-
Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 1987, 65:30-36. DCCT Research Group
-
(1987)
J Clin Endocrinol Metab
, vol.65
, pp. 30-36
-
-
-
9
-
-
0026084950
-
Symptomatic hypoglycaemia in 411 type 1 diabetic patients
-
Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991, 8:217-222.
-
(1991)
Diabet Med
, vol.8
, pp. 217-222
-
-
Pramming, S.1
Thorsteinsson, B.2
Bendtson, I.3
Binder, C.4
-
10
-
-
0028292096
-
Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia
-
Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994, 17:697-703.
-
(1994)
Diabetes Care
, vol.17
, pp. 697-703
-
-
Gold, A.E.1
MacLeod, K.M.2
Frier, B.M.3
-
11
-
-
0027409534
-
Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients
-
MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 1993, 10:238-245.
-
(1993)
Diabet Med
, vol.10
, pp. 238-245
-
-
MacLeod, K.M.1
Hepburn, D.A.2
Frier, B.M.3
|